Immune checkpoint inhibitors (ICIs) are novel immunotherapy-based drugs that have
become increasingly popular in the treatment of lung cancer. Researchers have recognized …

Simple Summary Cancer survivors can experience neurological complications after
exposure to anticancer therapy. Chemotherapy-induced peripheral neurotoxicity (CIPN) …

Abstract Introduction Immune checkpoint inhibitors (ICIs) have become an important part of
the treatment of multiple cancers, especially for advanced melanoma and non-small cell …

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung
cancer (NSCLC) accounts for approximately 80% of all lung cancers, and most NSCLC is …

Purpose Assessing immune-related ocular toxicities from immune checkpoint inhibitors
(ICIs) is crucial, though rare. This study, utilizing real-world data, examines the occurrence of …

Objective Describe the demographic data and clinical phenotype of cranial palsy induced by
immune checkpoint inhibitors (CNP-ICI). Methods A systematic literature review of the …

Purpose To characterize various ocular inflammatory complications arising from metastatic
cutaneous melanoma therapies and their management. Methods Retrospective case series …

Purpose: To help ophthalmologists and oncologists better understand the ocular irAEs
secondary to PD-1 inhibitors, enabling early detection and management of ocular …

We present a case of a patient with metastatic lung adenocarcinoma who developed severe
right lower limb radicular pain in a L5-S1 dermatomal distribution 5 months into treatment …

Pembrolizumab is a monoclonal antibody with anti-tumor effects. Only a few reports have
previously described retrobulbar optic neuritis induced by pembrolizumab. We herein report …